12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CureXcell: Phase IV data

An Israeli Phase IV trial in 131 patients with hard-to-heal chronic ulcers showed that CureXcell as an adjunct to good ulcer care in the community care setting led to complete wound closure at week 24 in 71% of all...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >